{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:02Z","timestamp":1772165582676,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular diseases are still the main cause of death in the western world. However, diminishing mortality rates of acute myocardial infarction (AMI) are motivating the need to investigate the process of secondary prevention after AMI. Besides cardiac rehabilitation, disease management programs (DMPs) are an important component of outpatient care after AMI in Germany. This study aims to analyze outcomes after AMI among those who participated in DMPs and cardiac rehabilitation (CR) in a region with overall increased cardiovascular morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on data from a regional myocardial infarction registry and a 2-year follow-up period, we assessed the occurrence of major adverse cardiac events (MACE) in relation to participation in CR and DMP, risk factors for complications and individual healths well as lifestyle characteristics. Multivariable Cox regression was performed to compare survival time between participants and non-participants until an adverse event occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1094 observed patients post-AMI, 272 were enrolled in a DMP. An association between DMP participation and lower hazard rates for MACE compared to non-enrollees could not be proven in the crude model (hazard ratio\u2009=\u20090.93; 95% confidence interval\u2009=\u20090.65\u20131.33). When adjusted for possible confounding variables, these results remained virtually unchanged (1.03; 0.72\u20131.48). Furthermore, smokers and obese patients showed a distinctly lower chance of DMP enrollment. In contrast, those who participated in CR showed a lower risk for MACE in crude (0.52; 0.41\u20130.65) and adjusted analysis (0.56; 0.44\u20130.71).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Participation in DMP was not associated with a lower risk of MACE, but participation in CR showed beneficial effects. Adjustment only slightly changed effect estimates in both cases, but it is still important to consider potential effects of additional\u00a0confounding variables.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01832-3","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T15:05:26Z","timestamp":1609945526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data"],"prefix":"10.1186","volume":"21","author":[{"given":"Christian","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"H\u00f6pner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Noutsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1271-7204","authenticated-orcid":false,"given":"Rafael","family":"Mikolajczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"1832_CR1","unstructured":"DESTATIS (Statistisches Bundesamt). Zahl der Todesf\u00e4lle im Jahr 2017 um 2,3 % gestiegen. 2019;1:1\u201313. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Todesursachen\/todesfaelle.html. Accessed 15 Nov 2019."},{"key":"1832_CR2","unstructured":"Deutsche Herzstiftung (German Heart Foundation). Deutscher Herzbericht 2018."},{"key":"1832_CR3","unstructured":"Gesundheitsberichterstattung des Bundes. Mortalit\u00e4tsstatistik GBE Bund. 2018. www.gbe-bund.de. Accessed 15 Jun 2019."},{"key":"1832_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-017-0482-9","volume":"17","author":"S Johansson","year":"2017","unstructured":"Johansson S, Rosengren A, Young K, Jennings E. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017;17:1\u20138.","journal-title":"BMC Cardiovasc Disord"},{"key":"1832_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2016.05.037","volume":"252","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representation). Atherosclerosis. 2016;252:207\u201374.","journal-title":"Atherosclerosis"},{"key":"1832_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.kjms.2015.04.012","volume":"31","author":"HM Chen","year":"2015","unstructured":"Chen HM, Liu CK, Chen HW, Shia BC, Chen M, Chung CH. Efficiency of rehabilitation after acute myocardial infarction. Kaohsiung J Med Sci. 2015;31:351\u20137. https:\/\/doi.org\/10.1016\/j.kjms.2015.04.012.","journal-title":"Kaohsiung J Med Sci"},{"key":"1832_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.hlc.2015.08.007","volume":"25","author":"E De Gruyter","year":"2016","unstructured":"De Gruyter E, Ford G, Stavreski B. Economic and social impact of increasing uptake of cardiac rehabilitation services\u2014a cost benefit analysis. Hear Lung Circ. 2016;25:175\u201383. https:\/\/doi.org\/10.1016\/j.hlc.2015.08.007.","journal-title":"Hear Lung Circ"},{"key":"1832_CR8","first-page":"e9785","volume":"97","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Cao HX, Jiang P, Tang HQ. Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention. Medicine (United States). 2018;97:e9785.","journal-title":"Medicine (United States)"},{"key":"1832_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","volume":"67","author":"L Anderson","year":"2016","unstructured":"Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67:1\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"1832_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00392-009-0081-6","volume":"98","author":"B Schweikert","year":"2009","unstructured":"Schweikert B, Hahmann H, Steinacker JM, Imhof A, Muche R, Koenig W, et al. Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation. Clin Res Cardiol. 2009;98:787\u201395.","journal-title":"Clin Res Cardiol"},{"key":"1832_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/HJR.0b013e3280128bde","volume":"14","author":"M Karoff","year":"2007","unstructured":"Karoff M, Held K, Bjarnason-Wehrens B. Cardiac rehabilitation in Germany. Eur J Prev Cardiol. 2007;14:18\u201327.","journal-title":"Eur J Prev Cardiol"},{"key":"1832_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Social. Eur Heart J. 2018;39:119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","journal-title":"Eur Heart J"},{"key":"1832_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of. Eur Heart J. 2016;37:267\u2013315.","journal-title":"Eur Heart J"},{"key":"1832_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1377\/hlthaff.23.3.56","volume":"23","author":"R Busse","year":"2004","unstructured":"Busse R. Disease management programs in Germany\u2019s Statutory Health Insurance System: a Gordian solution to the adverse selection of chronically ill people in competitive markets? Health Aff. 2004;23:56\u201367.","journal-title":"Health Aff"},{"key":"1832_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1055\/s-0042-110431","volume":"32","author":"A Baldus","year":"2016","unstructured":"Baldus A. Richtlinie des Gemeinsamen Bundesausschusses (G-BA) zur Zusammenf\u00fchrung der Anforderungen an strukturierte Behandlungsprogramme nach \u00a7 137f Abs. 2 SGB V. B&G Bewegungstherapie und Gesundheitssport. 2016;32:233\u2013233.","journal-title":"B&G Bewegungstherapie und Gesundheitssport"},{"key":"1832_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-015-0065-9","volume":"7","author":"M Laxy","year":"2015","unstructured":"Laxy M, Stark R, Meisinger C, Kirchberger I, Heier M, Von Scheidt W, et al. The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study. Diabetol Metab Syndr. 2015;7:1\u201311.","journal-title":"Diabetol Metab Syndr"},{"key":"1832_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00392-013-0643-5","volume":"103","author":"R Stark","year":"2014","unstructured":"Stark R, Kirchberger I, Hunger M, Heier M, Leidl R, Von Scheidt W, et al. Improving care of post-infarct patients: Effects of disease management programmes and care according to international guidelines. Clin Res Cardiol. 2014;103:237\u201345.","journal-title":"Clin Res Cardiol"},{"key":"1832_CR18","first-page":"856","volume":"108","author":"S Mangiapane","year":"2011","unstructured":"Mangiapane S, Busse R. Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction. Dtsch Aerzteblatt Online. 2011;108:856\u201363.","journal-title":"Dtsch Aerzteblatt Online"},{"key":"1832_CR19","first-page":"426","volume":"32","author":"R Lindner","year":"2015","unstructured":"Lindner R, Horenkamp-Sonntag D. Disease-management-programme. WiSt Wirtschaftswissenschaftliches Stud. 2015;32:426\u20138.","journal-title":"WiSt Wirtschaftswissenschaftliches Stud"},{"key":"1832_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.healthpol.2008.03.009","volume":"88","author":"O Gapp","year":"2008","unstructured":"Gapp O, Schweikert B, Meisinger C, Holle R. Disease management programmes for patients with coronary heart disease\u2014an empirical study of German programmes. Health Policy (New York). 2008;88:176\u201385.","journal-title":"Health Policy (New York)"},{"key":"1832_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/jech-2014-204506","volume":"69","author":"K Bozorgmehr","year":"2015","unstructured":"Bozorgmehr K, Maier W, Brenner H, Saum KU, Stock C, Miksch A, et al. Social disparities in Disease Management Programmes for coronary heart disease in Germany: a cross-classified multilevel analysis. J Epidemiol Commun Health. 2015;69:1091\u2013101.","journal-title":"J Epidemiol Commun Health"},{"key":"1832_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.zefq.2015.11.003","volume":"110\u2013111","author":"T Schulte","year":"2016","unstructured":"Schulte T, Mund M, Hofmann L, Pimperl A, Dittmann B, Hildebrandt H. Pilotstudie zur Evaluation des DMP Koronare Herzkrankheit - Entwicklung einer Methodik und erste Ergebnisse. Z Evid Fortbild Qual Gesundhwes. 2016;110\u2013111:54\u20139. https:\/\/doi.org\/10.1016\/j.zefq.2015.11.003.","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"1832_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-017-2162-y","volume":"17","author":"J R\u00f6ttger","year":"2017","unstructured":"R\u00f6ttger J, Bl\u00fcmel M, Busse R. Selective enrollment in Disease Management Programs for coronary heart disease in Germany\u2014an analysis based on cross-sectional survey and administrative claims data. BMC Health Serv Res. 2017;17:1\u201311.","journal-title":"BMC Health Serv Res"},{"key":"1832_CR24","first-page":"453","volume":"111","author":"S Fuchs","year":"2014","unstructured":"Fuchs S, Henschke C, Bl\u00fcmel M, Busse R. Disease management programs for type 2 diabetes in Germany. Dtsch Aerzteblatt Online. 2014;111:453\u201363.","journal-title":"Dtsch Aerzteblatt Online"},{"key":"1832_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/2048872616689773","volume":"6","author":"MF Piepoli","year":"2017","unstructured":"Piepoli MF, Corr\u00e0 U, Dendale P, Frederix I, Prescott E, Schmid JP, et al. Challenges in secondary prevention after acute myocardial infarction: a call for action. Eur Hear J Acute Cardiovasc Care. 2017;6:299\u2013310.","journal-title":"Eur Hear J Acute Cardiovasc Care"},{"key":"1832_CR26","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/eurheartj\/ehq388","volume":"32","author":"H Bueno","year":"2011","unstructured":"Bueno H, Armstrong PW, Buxton MJ, Danchin N, Lubsen J, Roland E, et al. The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J. 2011;32:1583\u20139.","journal-title":"Eur Heart J"},{"key":"1832_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12872-015-0040-2","volume":"15","author":"S Bohley","year":"2015","unstructured":"Bohley S, Trocchi P, Robra BP, Mau W, Stang A. The regional myocardial infarction registry of Saxony-Anhalt (RHESA) in Germany\u2014rational and study protocol. BMC Cardiovasc Disord. 2015;15:2\u20137. https:\/\/doi.org\/10.1186\/s12872-015-0040-2.","journal-title":"BMC Cardiovasc Disord"},{"key":"1832_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-016-0336-x","volume":"16","author":"K Hirsch","year":"2016","unstructured":"Hirsch K, Bohley S, Mau W, Schmidt-Pokrzywniak A. The RHESA-CARE study: an extended baseline survey of the regional myocardial infarction registry of Saxony-Anhalt (RHESA) design and objectives. BMC Cardiovasc Disord. 2016;16:1\u20136. https:\/\/doi.org\/10.1186\/s12872-016-0336-x.","journal-title":"BMC Cardiovasc Disord"},{"key":"1832_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jacc.2007.10.034","volume":"51","author":"KE Kip","year":"2008","unstructured":"Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies. J Am Coll Cardiol. 2008;51:701\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1832_CR30","volume-title":"Proper estimation of relative risk using PROC GENMOD in population studies Kechen Zhao","author":"K Zhao","year":"2013","unstructured":"Zhao K. Proper estimation of relative risk using PROC GENMOD in population studies Kechen Zhao. Los Angeles: University of Southern California; 2013."},{"key":"1832_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558\u201369. https:\/\/doi.org\/10.4097\/kja.19087.","journal-title":"Korean J Anesthesiol"},{"key":"1832_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcrc.2016.07.017","volume":"36","author":"M Jones","year":"2016","unstructured":"Jones M, Fowler R. Immortal time bias in observational studies of time-to-event outcomes. J Crit Care. 2016;36:195\u20139. https:\/\/doi.org\/10.1016\/j.jcrc.2016.07.017.","journal-title":"J Crit Care"},{"key":"1832_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183:758\u201364.","journal-title":"Am J Epidemiol"},{"key":"1832_CR34","unstructured":"aerzteblatt.de. Bundesl\u00e4nder setzen sich f\u00fcr Erhalt der DMP-Programmkostenpauschale ein. Bundesl\u00e4nder setzen sich f\u00fcr Erhalt der DMP-Programmkostenpauschale ein. 2019. https:\/\/www.aerzteblatt.de\/nachrichten\/sw\/DMP?nid=104319. Accessed 6 Jul 2019."},{"key":"1832_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/1472-6963-10-351","volume":"10","author":"I Sch\u00e4fer","year":"2010","unstructured":"Sch\u00e4fer I, K\u00fcver C, Gedrose B, Von Leitner EC, Treszl A, Wegscheider K, et al. Selection effects may account for better outcomes of the German disease management program for type 2 diabetes. BMC Health Serv Res. 2010;10:351. https:\/\/doi.org\/10.1186\/1472-6963-10-351.","journal-title":"BMC Health Serv Res"},{"key":"1832_CR36","unstructured":"Potthoff F, M\u00fcnscher C, Berendes A, Ruth T, Weber W. Bericht der strukturierten Behandlungsprogramme der gesetzlichen Krankenkassen \u2013 Indikation Koronare Herzkrankheit ( KHK ) Erstellt durch MNC und infas. 2018."},{"key":"1832_CR37","unstructured":"Stang A, Stang M. An inter-state comparison of cardiovascular risk factors in Germany. Dtsch Aerzteblatt Online. 2018."},{"key":"1832_CR38","first-page":"1","volume":"5","author":"T Gupta","year":"2016","unstructured":"Gupta T, Kolte D, Khera S, Harikrishnan P, Mujib M, Aronow WS, et al. Smoker\u2019s paradox in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Am Heart Assoc. 2016;5:1\u201310.","journal-title":"J Am Heart Assoc"},{"key":"1832_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijcard.2016.07.172","volume":"222","author":"M Saad","year":"2016","unstructured":"Saad M, Fuernau G, Desch S, Eitel I, Jung C, P\u00f6ss J, et al. \u201cSmoker\u2019s paradox\u201d in patients with cardiogenic shock complicating myocardial infarction\u2014a substudy of the IABP-SHOCK II-trial and registry. Int J Cardiol. 2016;222:775\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.172.","journal-title":"Int J Cardiol"},{"key":"1832_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-015-1039-1","volume":"15","author":"NK Brusco","year":"2015","unstructured":"Brusco NK, Watts JJ. Empirical evidence of recall bias for primary health care visits. BMC Health Serv Res. 2015;15:1\u20138. https:\/\/doi.org\/10.1186\/s12913-015-1039-1.","journal-title":"BMC Health Serv Res"},{"key":"1832_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/aogs.13319","volume":"97","author":"EA Nohr","year":"2018","unstructured":"Nohr EA, Liew Z. How to investigate and adjust for selection bias in cohort studies. Acta Obstet Gynecol Scand. 2018;97:407\u201316.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1832_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1073274818789355","volume":"25","author":"P Agarwal","year":"2018","unstructured":"Agarwal P, Moshier E, Ru M, Ohri N, Ennis R, Rosenzweig K, et al. Immortal time bias in observational studies of time-to-event outcomes: assessing effects of postmastectomy radiation therapy using the national cancer database. Cancer Control. 2018;25:1\u20137.","journal-title":"Cancer Control"},{"key":"1832_CR43","unstructured":"Statistische \u00c4mter des Bundes und der L\u00e4nder: https:\/\/www-genesis.destatis.de\/gis\/genView?GenMLURL=https:\/\/www-genesis.destatis.de\/regatlas\/AI-S-01.xml&CONTEXT=REGATLAS01. Accessed 19 Aug 2020."},{"key":"1832_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12872-020-01641-8","volume":"20","author":"J H\u00f6pner","year":"2020","unstructured":"H\u00f6pner J, Junge U, Schmidt-Pokrzywniak A, et al. Determinants of persistent smoking after acute myocardial infarction: an observational study. BMC Cardiovasc Disord. 2020;20:384. https:\/\/doi.org\/10.1186\/s12872-020-01641-8.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01832-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T16:10:36Z","timestamp":1609949436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01832-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01832-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-25395\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25395\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25395\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25395\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Medical Faculty of the Martin Luther University Halle-Wittenberg approved the RHESA study and the follow up questionnaires RHESA CARE 1 and 2, and recently RHESA CARE 3. Written informed consent was obtained from all RHESA participants by the doctors working in the collaborating hospitals of the RHESA registry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"Michael Noutsias declares that he serves on the editorial board of BMC Cardiovascular Disorders. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}